Pediatric Vaccine Market to exceed US$ 48 Billion by 2024

1
Pediatric Vaccine Market
Category Vaccines Market Research Report
2
Pediatric Vaccine Market Analyst View
Pediatric Vaccine Market is projected to exceed
US 48 Billion by 2024. Get Free Customization
in this Report Research Report Title
Pediatric Vaccine Market, Global Forecast
Infants Vaccinated, Vaccines Administered,
Immunization, By Disease (Influenza, MMR,
Pneumonia, Meningitis, Hepatitis, Tap, Hib,
Polio, etc) Companies Access Full
Research  https//www.renub.com/pediatric-vaccine
s-market-doses-immunization-cases-and-forecast-wor
ldwide-analysis-166-p.php

3
Pediatric Vaccine Market is projected to exceed
US 48 Billion by 2024.
As per Renub Research analysis Pediatric Vaccine
Market is projected to exceed US 48 Billion by
the year 2024. Increasing government and
non-government funding for the development of new
vaccines, along with raising awareness about the
benefits of vaccination, is certainly expected to
positively drive the market growth in the coming
years. In order to cut the healthcare expenses,
governments have been making continuous efforts
to reduce the cost of patient immunization
through various vaccination programs funded by
government or non-government health
authorities. For example several countries have
included Children Vaccination Programs, which
offers vaccines to children who lack health
insurance or one who cannot afford the cost of
vaccination. Growing prevalence of chronic
diseases is another major market driver, driving
the market of infant (pediatric) vaccines. The
immune system is not fully developed in infants,
hence they are at a higher risk of contracting
severe diseases and so, vaccination plays a
significant role in their prevention. According
to WHO effective immunization activities have
had a major impact on reducing measles deaths. It
is found that measles vaccination prevented an
estimated 20.4 million deaths across the globe.
Global measles deaths have decreased by 84 from
an estimated 550,100 in 2000 to 89,780 in 2016. 

4
Pediatric Vaccine Market is projected to exceed
US 48 Billion by 2024.
Request a free sample copy of the
report https//www.renub.com/contactus.php  Renu
b Research report titled Pediatric Vaccine
Market, Global Forecast Infants Vaccinated,
Vaccines Administered, Immunization, By Disease
Influenza, MMR (Measles, Mumps, and Rubella),
Pneumonia, Meningitis, Hepatitis, Tap
(Diphtheria, Tetanus, Pertussis), Haemophilus
influenzae type B (Hib), Polio, Rotavirus,
Varicella, and Combination Vaccine, Companies
(GlaxoSmithKline, Merck, Sanofi, Pfizer,
Others) provides a complete analysis of Global
Pediatric (Infants) Vaccine Market. By Disease -
Pneumococcal Vaccine is likely to grow at
Noteworthy Rate in the Forthcoming Years The
report studies the market of the following
vaccine Influenza, MMR (Measles, Mumps, and
Rubella), Pneumonia, Meningitis, Hepatitis, Tap
(Diphtheria, Tetanus, Pertussis), Haemophilus
influenzae type B (Hib), Polio, Rotavirus,
Varicella, and Combination Vaccine. Pneumococcal
and Combination Vaccines together hold the
significant market share in pediatric (infants)
vaccine market and is expected to continue so
during the forecast period.

5
Pediatric Vaccine Market is projected to exceed
US 48 Billion by 2024.

6
Pediatric Vaccine Market is projected to exceed
US 48 Billion by 2024.
Nearly 650 Million Vaccines Doses will be
administered in Pediatrics (Infants) by the year
2024 As per our analysis it is estimated that by
the year 2024, the doses of vaccines administered
will reach nearly 650 Million. The number of
vaccine doses is expected to grow considerably
during the forecast period due to growing
awareness among the parents about the benefits of
vaccines and also the developing countries around
the world that now have included a number of
vaccines to their national immunization programme
as per WHO recommendations, which indeed will
drive the pediatric vaccine market in recent
years.   Regional - Immunization Profile The
report also comprises of the en-detail study of
global and regional immunization profile By
Diseases such as Measles, Mumps, Rubella,
Diphtheria, Tetanus, Polio and so on and By
Regions such as Africa (AFR), Americas (AMR),
Eastern Mediterranean (EMR), Europe (EUR),
South-East Asia (SEAR), Western Pacific (WPR) and
Global.   Company Analysis GlaxoSmithKline,
Merck, Sanofi, Pfizer are some of top companies
that deal efficiently in vaccine business
globally. These companies have been studied
thoroughly in the report.

7
Pediatric Vaccine Market is projected to exceed
US 48 Billion by 2024.
Pediatric Vaccine Market has been extensively
studied from 3 major points   1.    Pediatrics
Vaccines (Disease wise) Market Forecast2.  
 Number of Vaccinated Pediatric (Infants)
(Disease wise) Forecast3.    Doses of Vaccines
Administered in Pediatric (Infants) (Disease
wise) Forecast     Client can Purchase
this Report in Sections from below link Access
full Research https//www.renub.com/pediatric-vac
cines-market-doses-immunization-cases-and-forecast
-worldwide-analysis-166-p.php    This market
research report provides a complete analysis of
the Global Pediatric (Infants) Vaccine Market and
their projections for the upcoming years, Growth
Drivers, Challenges, Disease wise number of
reported cases.   By Disease   
 Influenza     MMR (Measles, Mumps, and
Rubella)    Pneumonia     Meningitis  
 Hepatitis     Tap (Diphtheria, Tetanus,
Pertussis)    Haemophilus influenzae type
B     Polio    Rotavirus   
 Varicella    Combination Vaccine 

8
Table of Contents for Global Vaccine Market

• Key Companies Covered in the Report
•     GlaxoSmithKline    Merck    Sanofi  
   Pfizer
• Key Topics Covered
• 1. Research Findings
• 2. Pediatric (Infant) Vaccines Market (2011
  2024)
• 3. Market Numbers Share Pediatric Vaccines
• 3.1 Pediatric Vaccine Market Share
• 3.2 Pediatric Vaccinated Population Share
• 3.3 Pediatric Doses of Vaccines Administered
  Share
• 3.4 Vaccine Companies Market Share
• 4. Pediatric Vaccinated Numbers
• Pediatric Doses of Vaccines Administered

9
Table of Contents for Global Vaccine Market
6.    Disease wise Pediatric (Infants) Vaccines
Market (2011 2024) 6.1    Influenza 6.2  
 MMR (Measles, Mumps, Rubella) 6.3  
 Pneumococcal 6.4    Meningococcal 6.5  
 Hepatitis 6.6    DTaP 6.7    Haemophilus
Influenzae Type B (HIB) 6.8    Combos
(Combination) 6.9    Polio 6.10  
 Rotavirus 6.11    Varicella 7.    Disease wise
Numbers of Vaccinated Pediatric (Infants) (2011
2024) 7.1    Influenza 7.2    MMR 7.3  
 Pneumococcal 7.4    Meningococcal 7.5  
 Hepatitis 7.6    DTaP 7.7    Hib (Haemophilus
Influenzae Type B) 7.8    Combos (Combination
Vaccines) 7.9    Polio 7.10  
 Rotavirus 7.11    Varicella 8.    Disease wise
Doses of Vaccines Administered in Pediatric
(Infants) (2011 2024) 8.1    Influenza 8.2  
 MMR 8.3    Pneumococcal 8.4  
 Meningococcal 8.5    Hepatitis 8.6  
 DTaP 8.7    Hib (Haemophilus Influenzae Type
B) 8.8    Polio 8.9    Rotavirus 8.10  
 Varicella

10
Table of Contents for Global Vaccine Market
9.    Disease wise - Immunization Profile 9.1  
 Immunization Coverage () in Infants 9.2  
 Global Immunization Profile 9.3    Regional
Immunization Profile 10.    Vaccines Key Players
Sales (2011 2024) 10.1    GlaxoSmithKline,
plc.s Vaccines Sales 10.2    Merck Co.
Vaccines Sales 10.3    Sanofi Pasteurs Vaccines
Sales 10.4    Pfizer, Inc.s Vaccines
Sales 10.5    Global Other Companies Vaccines
Sales 11.    Vaccines Products and
Pipeline 11.1    GSK Vaccine Product
Pipeline 11.2    Merck Vaccine Product
Pipeline 11.3    Sanofi Vaccine Product
Pipeline 11.4    Pfizer Vaccine Product
Pipeline 12.    Top Mergers and Acquisitions in
the Vaccine Industry 13.    Vaccines and
Regulators Interventions 13.1    Making and
Meeting Standards of Quality and Safety 13.2  
 Vaccine Funding

11
Table of Contents for Global Vaccine Market
14.    Vaccine Market Drivers 14.1    Inclusion
in National Immunization Schedule 14.2    Growing
Immunization Coverage for HPV Vaccines 14.3  
 Increase in Prevalence of Infectious
Diseases 14.4    Global Immunization Vision and
Strategy (GIVS) 14.5    GAVI Model Fuelling
Vaccine Manufacturers 14.6    Increasing Vaccine
Availability in United States 14.7    The Vaccine
Safety Data link Project 14.8    The Vaccine
Injury Compensation Program 14.9    Transforming
of Vaccine Technologies 14.10    Global Vaccine
Action Plan by WHO (2011 - 2020) 14.11  
 Continuous Focus on Effective Communication
Strategies 15.    Vaccines Market
Challenges 15.1    Hurdles to Optimal use of
Licensed Vaccines 15.2    Complexity of Vaccine
Development Approval System Thwarts Product
Development 15.3    Shortening the Timeline for
Vaccine Development 15.4    Refusal/Resistance to
Vaccination 15.5    Vaccine Shortages and
Delays 15.6    Obstacles in Vaccine Research
Development 15.7    Barriers to New Entrants in
the Vaccines Market

12
Get Free Customization in this Report

Vaccines Market Reports https//www.renub.com/va
ccines-12-c.php
Renub Research - North America Rajat Gupta 225 Kristie Ln, Roswell Georgia 30076, United States Tel [phone] Email info_at_renub.com www.renub.com Renub Research - Asia Ankit Mishra C 86, Sector 10 Noida 201301, India Tel [phone] Email info_at_renub.com www.renub.com